1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Osteogenic Sarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harvey, W; Hopps, RM; Murphy, CT; Wasil, M | 1 |
| Frick, KK; Scher, CD; Womer, RB | 1 |
| Grignani, G; Jamieson, GA | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Osteogenic Sarcoma
| Article | Year |
|---|---|
Biosynthesis of platelet activating factor (PAF) by an osteosarcoma cell line (UMR 106).
Topics: Animals; Azepines; Cell Line; Enzyme Activation; Kinetics; Osteosarcoma; Phospholipases A; Platelet Activating Factor; Platelet Aggregation; Rats; Sarcoma, Experimental; Triazoles | 1991 |
Platelet-derived growth factor-induced c-myc RNA expression. Analysis of an inducible pathway independent of protein kinase C.
Topics: Calcimycin; Cycloheximide; Egtazic Acid; Ethers; Gene Expression Regulation; Humans; Ionomycin; Oncogenes; Osteosarcoma; Platelet Activating Factor; Protein Kinase C; RNA; Tumor Cells, Cultured | 1988 |
Tissue factor-dependent activation of platelets by cells and microvesicles of SK-OS-10 human osteogenic sarcoma cell line.
Topics: Antibodies; Blood Platelets; Cell Line; Creatine Kinase; Hirudins; Humans; Inclusion Bodies; Lung Neoplasms; Osteosarcoma; Phosphocreatine; Phospholipases; Platelet Activating Factor; Platelet Aggregation; Thromboplastin | 1987 |